NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1710184031 MD
Verify on CMS → Yemul Almecci, MD
Endocrinology, Diabetes & Metabolism Physician in Rockville, Maryland.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 200 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
49%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Yemul Almecci, MD reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 1,730 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 2K
- Part D claims, 2023
- 49%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Yemul Almecci, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Yemul Almecci, MD sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Yemul Almecci, MD writes more Part D claims than 38% of them and scores higher on MIPS quality than 15% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Yemul Almecci, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Yemul Almecci, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Yemul Almecci, MD?
Below national averagePrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,730 34% vs specialty avg
MIPS final score
75/100 8.1 pts vs avg
Specialty distribution in Maryland
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Maryland providers
Medicare quality performance, MIPS
Yemul Almecci, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 75/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Yemul Almecci, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 12345 PARKLAWN DRIVE, Rockville, MD, 20852, with a listed phone of (240) 599-7772. NPI 1710184031 was issued on 06/29/2007.
Medicare Part D records for calendar year 2023 show 1,730 prescription claims written by this provider, covering 200 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 46% brand-name and 49% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1710184031 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/29/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
Avg: 83.1
Reporting: Group practice
Brand vs generic prescribing mix · Above average
Yemul Almecci, MD - brand share 46.0%
Endocrinology, Diabetes & Metabolism Physician average
46% brand-name claims vs 49% generic, on 1,730 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,730
Total Claims
$1.0M
Total Drug Cost
200
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,541
- Total Day Supply
- 134,923
- Brand vs Generic
- 46% brand / 49% generic
- Brand Drug Cost
- $987K
- Generic Drug Cost
- $20K
Patient Demographics
- Average Patient Age
- 73.5 years
- Avg HCC Risk Score
- 1.13
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 12, 65-74: 86, 75-84: 81, 85+: 21
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Yemul Almecci, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
188 claims
- Metformin Hcl
Metformin Hcl
129 claims
- Synthroid
Synthroid
100 claims
- Atorvastatin Calcium
Atorvastatin Calcium
99 claims
- Ozempic
Ozempic
88 claims
- Metformin Hcl Er 65
Metformin Hcl Er
65 claims
- Trulicity 59
Trulicity
59 claims
- Humalog Kwikpen U-… 50
Humalog Kwikpen U-100
50 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 188 |
| Metformin Hcl | 129 |
| Synthroid Levothyroxine Sodium | 100 |
| Atorvastatin Calcium | 99 |
| Ozempic Semaglutide | 88 |
| Metformin Hcl Er Metformin Hcl | 65 |
| Trulicity Dulaglutide | 59 |
| Humalog Kwikpen U-100 Insulin Lispro | 50 |
| Glimepiride | 49 |
| Tresiba Flextouch U-100 Insulin Degludec | 49 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in MD →
All providers in Maryland →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Yemul Almecci, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Yemul Almecci, MD's 1,730 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as Almecci.
Dr. Smita Abraham
MD
Silver Spring, MD
Dr. Georgette Abrell
RN
Baltimore, MD
Dr. Marnie Aguasvivas Bello
M.D.
Baltimore, MD
Dr. Rexford Ahima
MD
Baltimore, MD
Dr. Sabreen Ahmed
MD
Greenbelt, MD
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Maryland medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Maryland
Frequently Asked Questions
What is Yemul Almecci, MD's specialty? ▼
Yemul Almecci, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Rockville, Maryland. Credentials: MD.
How much does Yemul Almecci, MD prescribe under Medicare Part D? ▼
In 2023, Yemul Almecci, MD wrote 1,730 Medicare Part D claims totaling $1.0M in drug costs for 200 beneficiaries.
What is Yemul Almecci, MD's Medicare quality score? ▼
Yemul Almecci, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Yemul Almecci, MD located? ▼
Yemul Almecci, MD is located at 12345 PARKLAWN DRIVE, Rockville, MD, 20852. Phone: (240) 599-7772.
What is Yemul Almecci, MD's NPI number? ▼
Yemul Almecci, MD's National Provider Identifier (NPI) is 1710184031, issued on 06/29/2007.
Does Yemul Almecci, MD prescribe more brand-name or generic drugs? ▼
Yemul Almecci, MD's prescribing is 46% brand-name and 49% generic drugs by claim count, with $987K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Yemul Almecci, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Yemul Almecci, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Synthroid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Yemul Almecci, MD accept Medicare? ▼
Yemul Almecci, MD appears in CMS Medicare data with 1,730 Part D claims and 200 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Yemul Almecci, MD's credentials? ▼
Yemul Almecci, MD's NPI is 1710184031 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.